Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PR-PHOENIX: S-1 plus intravenous and intraperitoneal paclitaxel for gastric cancer with peritoneal metastasis
jRCTs031180025Completed
- Start
- Oct 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tegafur and paclitaxel in gastric cancer (GC). Primary endpoint: safety. Started Oct 2016; status: completed.
02
Drugs
tegafurpaclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on jRCTs031180025.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180025.